We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Heart's Oxygen Supply Sufficient in Hypothermia

By HospiMedica staff writers
Posted on 23 Aug 2006
A new study may have ruled out insufficient oxygen supply to the heart as the critical variable in whether a mammal's heart survives while in a hypothermic state.

Researchers from the University of Tromsø (Norway) and the University Hospital of North Norway (Tromso) divided anesthetized rats into three groups: two hypothermic groups and a control group. More...
They exposed one hypothermic group to 15°C for one hour before rewarming. They exposed the second group also to 15°C, but for five hours. The control group was kept at normal temperature, 37°C. The researchers followed the hemodynamic changes during hypothermia and rewarming and later examined the rats' heart cells.

When core body temperature was lowered to 15°C, both hypothermic groups experienced a similar reduction in circulating blood volume. Both showed that the physiologic mechanisms that help transport oxygen and help unload oxygen from hemoglobin were working. From that, the researchers concluded that oxygen supply was not a limiting factor for survival in the experiments. And while the rats in the one-hour group spontaneously normalized their blood pressure, cardiac output, and heart rate after they were rewarmed, the rats in the five-hour group experienced substantial lowering of cardiac output and other cardiac functions, and were more likely to experience fatal heart failure during rewarming. The study was published in the July 2006 issue of the American Journal of Physiology-Heart and Circulatory Physiology.

"We conclude that the heart failure we see after rewarming is not due to a lack of oxygen supply or oxygen transportation because unloading of oxygen at the cell level from hemoglobin is functioning,” said lead author Dr. Torkjel Tveita, an anesthesiologist who treats victims of hypothermia. He added that it appears that the problem comes as a result of the lower cardiac output.

Rewarming of victims of severe hypothermia almost always causes heart failure of varying severity, but little is known about why that happens. Doctors typically cease cardiopulmonary resuscitation (CPR) efforts in a normothermic patient after 30 minutes, but based on this study, the authors recommend that CPR should continue on hypothermic patients until after they have returned to normal temperature.



Related Links:
University of Tromsø
University Hospital of North Norway

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.